See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
Social Media
Artificial Intelligence
Tariffs
Eid
Stock Markets
Taxes
Donald Trump
Tesla
Infrastructure
Education
European Union
Published • loading... • Updated

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...

Summary by Post Register
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In TransMedics To Contact Him Directly To Discuss Their Options

3 Articles

All
Left
Center
2
Right
BenzingaBenzinga
Center

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Monolithic Power Systems - Monolithic Power Systems (NASDAQ:MPWR)

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Monolithic Power Systems To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Monolithic Power Systems between February 8, 2024 and November 8, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 …

·New York, United States
Read Full Article
Post RegisterPost Register
Center

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In TransMedics To Contact Him Directly To Discuss Their Options

Read Full Article
dailyguardian.cadailyguardian.ca

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Neumora To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in Neumora pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Offering Documents”) issued in connection with Neumora’s September 2023 initial public offering (the “IPO”) …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Post Register broke the news in on Sunday, March 30, 2025.
Sources are mostly out of (0)

Similar News Topics

United States

United States

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal